The company has also added a group of industry experts to its advisory board.
Douglas most recently led Bridge4Bio, a business consultancy. Prior to this he was managing director and president of Hoefer, a division of Harvard Bioscience.
The new members of the advisory board are Lori Kunkel, who has held various senior positions in the industry, including chief medical officer at Proteolix/Onyx Pharmaceuticals and vice president of clinical development at Xenocor, and Paul Nowak, ceo of Biotix Holdings.
Nowak has spent the majority of his career at VWR International, a global distributor of laboratory supplies, where he held many positions, including ceo and president.
BioCision appoints coo
Also expands corporate advisory board
You may also like
Manufacturing
Frontline innovation: dispatches from the show floor at CPHI Frankfurt (part II)
Industry leaders at CPHI Frankfurt are embracing emerging technologies — including automation, AI, advanced analytics and innovative manufacturing platforms — to drive efficiency, quality, scalability and sustainability in pharmaceutical production and development